Evidence map›Paper›PMID 22615298›Full record

ArticleThe Journal of antimicrobial chemotherapy2012

Wall teichoic acid protects Staphylococcus aureus from inhibition by Congo red and other dyes.

Takashi Suzuki, Jennifer Campbell, Younghoon Kim, Jonathan G Swoboda, Eleftherios Mylonakis, Suzanne Walker, Michael S Gilmore

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 38 citations in OpenAlex.

  1. Science advances · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibiotics (Basel, Switzerland) · 2021
    Article
  13. Review
  14. Frontiers in microbiology · 2021
    Article
  15. Inactivation of theMicroorganisms · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Genome-wide screen for genes involved in eDNA release during biofilm formation byProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Takashi SuzukiDepartment of Ophthalmology, Harvard Medical School, Boston, MA 02114, USA.
Jennifer Campbell
Younghoon Kim
Jonathan G Swoboda
Eleftherios Mylonakis
Suzanne Walker
Michael S Gilmore
Harvard University · USJeonbuk National University · KRMassachusetts General Hospital · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI Michael S Gilmore · 2009 to 2026
$39.4M
TOXINS AND ENDOPHTHALMITISR01EY008289 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI GILMORE, MICHAEL S, GREGORY-KSANDER, MEREDITH · 1989 to 2012
$3.7M
Adherence and Colonization in KeratitisR01EY017381 · NEI · SCHEPENS EYE RESEARCH INSTITUTE · PI GILMORE, MICHAEL S · 2007 to 2011
$2.0M
Wall Teichoic Acid Biosynthesis: A New Target for Therapeutic Intervention?R01GM078477 · NIGMS · HARVARD MEDICAL SCHOOL · PI WALKER, SUZANNE · 2007 to 2010
$1.7M
Discovery of Small Molecules that Restore Methicillin Sensitivity to MRSAF32AI084316 · NIAID · HARVARD MEDICAL SCHOOL · PI BUTLER, JENNIFER CAMPBELL · 2009 to 2010
$85k
NEI NIH HHS EY017381NEI NIH HHS EY08289NIAID NIH HHS AI083214NIAID NIH HHS F32AI084316NIGMS NIH HHS GM078477NIGMS NIH HHS R01 GM078477
6 · The paper itself

Abstract

objectivesPolyanionic polymers, including lipoteichoic acid and wall teichoic acid, are important determinants of the charged character of the staphylococcal cell wall. This study was designed to investigate the extent to which teichoic acid contributes to protection from anionic azo dyes and to identify barriers to drug penetration for development of new antibiotics for multidrug-resistant Staphylococcus aureus infection.

methodsWe studied antimicrobial activity of azo dyes against S. aureus strains with or without inhibition of teichoic acid in vitro and in vivo.

resultsWe observed that inhibition of wall teichoic acid expression resulted in an ∼1000-fold increase in susceptibility to azo dyes such as Congo red, reducing its MIC from >1024 to <4 mg/L. Sensitization occurred when the first step in the wall teichoic acid pathway, catalysed by TarO, was inhibited either by mutation or by chemical inhibition. In contrast, genetic blockade of lipoteichoic acid biosynthesis did not confer Congo red susceptibility. Based on this finding, combination therapy was tested using the highly synergistic combination of Congo red plus tunicamycin at sub-MIC concentrations (to inhibit wall teichoic acid biosynthesis). The combination rescued Caenorhabditis elegans from a lethal challenge of S. aureus.

conclusionsOur studies show that wall teichoic acid confers protection to S. aureus from anionic azo dyes and related compounds, and its inhibition raises the prospect of development of new combination therapies based on this inhibition.

Indexed as

Anti-Bacterial AgentsAzo CompoundsCell WallCongo RedHumansMicrobial Sensitivity TestsStaphylococcus aureusTeichoic AcidsAnti-Bacterial AgentsAzo CompoundsCongo RedTeichoic Acids

Identifiers

PMID22615298
PMCPMC3584970
OpenAlexW2170598045

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.